Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Leukemia and CXCR4[original query] |
---|
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006 Sep 20 (11): 1913-5. Dommange Florence, Cartron Guillaume, Espanel Claire, Gallay Nathalie, Domenech Jorge, Benboubker Lotfi, Ohresser Marc, Colombat Philippe, Binet Chistian, Watier Herve, Herault Olivier, |
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia. Blood 2009 Nov 114 (23): 4843-6. Crowther-Swanepoel Dalemari, Qureshi Mobshra, Dyer Martin J S, Matutes Estella, Dearden Claire, Catovsky Daniel, Houlston Richard |
The prognostic value of CXCR4 in acute myeloid leukemia. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2013 Jan 21 (1): 79-84. Ahn Jeong Yeal, Seo Katie, Weinberg Olga K, Arber Daniel |
Stromal cell derived factor-1 (CXCL12) chemokine gene variant in myeloid leukemias. Clinical laboratory 2014 60 (5): 735-41. El-Ghany Hoda Mohamed A, El-Saadany Zainab Ali, Bahaa Nevien Mohamed, Ibrahim Noha Yehia, Hussien Salwa Mahmo |
Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 Jul 20 (7): 986-91. Szmigielska-Kaplon Anna, Szemraj Janusz, Hamara Katarzyna, Robak Marta, Wolska Anna, Pluta Agnieszka, Czemerska Magdalena, Krawczynska Anna, Jamroziak Krzysztof, Szmigielska Katarzyna, Robak Tadeusz, Wierzbowska Agniesz |
The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination. Gene 2016 May . Qin Zheng, Xiao Shuai, Yuan-Xin Ye, Yong-Mei Jin, Neng-Gang Jiang, Xing-Yuan Chen, Jun |
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric blood & cancer 2016 May . Matsuo Hidemasa, Nakamura Naomi, Tomizawa Daisuke, Saito Akiko Moriya, Kiyokawa Nobutaka, Horibe Keizo, Nishinaka-Arai Yoko, Tokumasu Mayu, Itoh Hiroshi, Kamikubo Yasuhiko, Nakayama Hideki, Kinoshita Akitoshi, Taga Takashi, Tawa Akio, Taki Tomohiko, Tanaka Shiro, Adachi Souic |
Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia. HLA 2016 May . Butrym A, Gebura K, Iwaszko M, Kuliczkowski K, Bogunia-Kubik K, Mazur |
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Annals of hematology 2017 Mar . Cao Xin-Xin, Meng Qi, Cai Hao, He Tian-Hua, Zhang Cong-Li, Su Wei, Sun Jian, Li Yue, Xu Wei, Zhou Dao-Bin, Li Ji |
Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation. Experimental hematology 2018 4 63 17-21.e1. Azoulay David, Herishanu Yair, Shapiro Mika, Brandshaft Yarden, Suriu Celia, Akria Luiza, Braester Andr |
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood 2019 9 134 (21): 1821-1831. Chapiro Elise, Pramil Elodie, Diop M'boyba, Roos-Weil Damien, Dillard Clémentine, Gabillaud Clémentine, Maloum Karim, Settegrana Catherine, Baseggio Lucile, Lesesve Jean-François, Yon Mélanie, Jondreville Ludovic, Lesty Claude, Davi Frédéric, Le Garff-Tavernier Magali, Droin Nathalie, Dessen Philippe, Algrin Caroline, Leblond Véronique, Gabarre Jean, Bouzy Simon, Eclache Virginie, Gaillard Baptiste, Callet-Bauchu Evelyne, Muller Marc, Lefebvre Christine, Nadal Nathalie, Ittel Antoine, Struski Stéphanie, Collonge-Rame Marie-Agnès, Quilichini Benoit, Fert-Ferrer Sandra, Auger Nathalie, Radford-Weiss Isabelle, Wagner Lena, Scheinost Sebastian, Zenz Thorsten, Susin Santos A, Bernard Olivier A, Nguyen-Khac Florence, , |
CD97 expression is associated with poor overall survival in acute myeloid leukemia. Experimental hematology 2019 7 75 64-73.e4. Vaikari Vijaya Pooja, Yang Jiawen, Wu Sharon, Alachkar Hou |
High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. Journal of translational medicine 2019 6 17 (1): 191. Du Wen, He Jing, Zhou Wei, Shu Simin, Li Juan, Liu Wei, Deng Yun, Lu Cong, Lin Shengyan, Ma Yaokun, He Yanli, Zheng Jine, Zhu Jiang, Bai Lijuan, Li Xiaoqing, Yao Junxia, Hu Dan, Gu Shengqing, Li Huiyu, Guo Anyuan, Huang Shiang, Feng Xiaolan, Hu Do |
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood 2020 11 137 (20): 2800-2816. Klintman Jenny, Appleby Niamh, Stamatopoulos Basile, Ridout Katie, Eyre Toby A, Robbe Pauline, Pascua Laura Lopez, Knight Samantha J L, Dreau Helene, Cabes Maite, Popitsch Niko, Ehinger Mats, Martín-Subero Jose I, Campo Elías, Månsson Robert, Rossi Davide, Taylor Jenny C, Vavoulis Dimitrios V, Schuh An |
Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients. Asian Pacific journal of cancer prevention : APJCP 2021 Apr 22 (4): 1035-1043. Aladle Doaa Abd Allah M, Ghannam Mayada A, El-Ashwah Shaimaa, Ghobrial F E I, Mortada Metwaly Ibrah |
Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML. Frontiers in cell and developmental biology 2021 9 641629. Yu Dong-Hu, Chen Chen, Liu Xiao-Ping, Yao Jie, Li Sheng, Ruan Xiao-L |
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia. Neoplasia (New York, N.Y.) 2021 3 23 (4): 361-374. Wang Yingjun, Gali Vasantha Lakshmi, Xu-Monette Zijun Y, Sano Dahlia, Thomas Sheeba K, Weber Donna M, Zhu Feng, Fang Xiaosheng, Deng Manman, Zhang Mingzhi, Hagemeister Fredrick B, Li Yong, Orlowski Robert Z, Lee Hans Chulhee, Young Ken |
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers 2023 9 15 (18): . Jan Korbecki, Patrycja Kupnicka, Katarzyna Barczak, Mateusz Bosiacki, Pawe? Zi?tek, Dariusz Chlubek, Irena Baranowska-Bosiac |
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets. Neurology(R) neuroimmunology & neuroinflammation 2023 5 10 (4): . Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Cinzia Candiotto, Claudia Baratè, Alessandro Cellini, Roberta Bertorelle, Gabriele Siciliano, Livio Trentin, Chiara Bria |
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 OF1-OF10. Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestn |
Gata2 Noncoding Genetic Variation as a Determinant of Hematopoietic Stem/Progenitor Cell Mobilization Efficiency. Blood advances 2023 10 . Alexandra A Soukup, Emery H Bresni |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: